Hasil Pencarian  ::  Simpan CSV :: Kembali

"Describes the miraculous breakthroughs scientists have made in the past decade and dispels the many myths and misunderstandings surrounding stem cell research and therapeutic cloning, offering a window into the astonishing potential of regenerative medicine to extend the human life span and cure disease. Annotation. The extraordinary story of the breakthrough discoveries in cell aging, stem cell research, and therapeutic cloning, and the tremendous promise they hold for dramatically extending human life. Dr. Michael West has been consumed with the mystery of science since he was as an inquisitive child mixing chemicals in his attic-turned-laboratory. Today, he stands in the center of a controversy so great that the list of those lining up against him includes President George W. Bush. Once a devoted creationist eager to dispel theories of human evolution, Dr. West was set on a quest to find a scientific solution to the devastating effects of disease and death after the death of his father. He became immersed in the study of cell aging and the discovery of the cellular "clock" telomerase - the mechanism that controls cell aging. His work led him to found the biotechnology company Geron, a pioneer in the field of stem cell research. His new company, Advanced Cell Technology, is the only organization in the United States pursuing human therapeutic cloning research - research in the field of "regenerative medicine" intended to repair damaged and diseased human organs and tissues. Unlike reproductive cloning, the attempt to clone a human child, therapeutic cloning is a process of growing cells, using a patient's own DNA that is inserted it into an unfertilized egg cell to create embryonic stem cells, cells that hold the promise of repairing the damage of age and disease - in essence, making the cell young again. The potential for therapeutic cloning to treat afflictions caused by the loss of dysfunction of cells - from spinal cord injury and skin burns to kidney failures and cancer - is enormous. Part memoir, part adventure story, The Immortal Cell chronicles the breakthroughs Dr. West and other scientists have made in biotechnology over the past decade - and the astonishing potential they offer us to cure diseases and improve the quality of human life."

"Latar Belakang: APOBEC3G, apolipoprotein B mRNA-editing enzyme, catalytic polypeplidelike JG, merupakan protein manusia yang dapat mengganggu replikasi HIV dengan memasukkan dirinya ke dalam partikel virus dan merusak susunan materi genetik virus. Beberapa studi terbaru menunjukkan bahwa APOBEC3G manusia mengatur infektivitas HIV-1 dengan mendeaminasi dC menjadi dU pada rantai minus DNA yang baru dibentuk, menyebabkan hipermutasi G menjadi A dari rantai plus DNA viral.Induksi hlpermutasi oleh APOBEC3G dapat menyebabkan pembentukan stop kodon pada ORF protein virus dan memicu degradasi DNA virus oleh glikosilase DNA urnsil yang selanjutuya dapat menghambat replikasi HIV. Protein ini layak untuk diteliti lebih lanjut dalam rangka pengembangan anti retrovirus yang berbasis pacta mekanisme penghambatan replikasi HIV-1 melalui jalur APOBEC3G. Sebagai langkab awal, diperlukan sistem ekspresi gen APOBEC3G yang akan diperoleh melalui sintesis dan kloning gen APOBEC3G ke dalam vektor ekspresi DNA rekombinan.Metode: Untuk mendapatkan mRNA APOBEC3G yang akan digunakan sebagai pola cetak dalam sintesis eDNA APOBEC3G, dilalkukan ekstraksi RNA dari sel CEM-GFP menggunakan Rneasy Mini Kit. Agar DNA APOBEC3G lengkap dapat diperoleh dengan lebih mudah, sintesis DNA serat ganda APOBEC3G menggunakan reaksi RT-PCR dua tahap, dibagi atas tiga daerah pada gen APOBEC3G dengan susunan nukleotida yang bertumpang tindih (overlapping) pada bagian ujung segmen DNA yang akan berfungsi sebagai penyambung fragmen-fragmen tersebut menjadi DNA APOBEC3G utub.Hasil: Hasil eksperimen menunjukloan ketiga fragmen APOBEC3G yang masing-masing berukuran 452 pb, 458 pb,dan 433 pb berhasil dibentuk lewat reaksi PCR dengan menggunakan enzim Pfx dan diklona ke dalam vektor plasmid.Kesimpulan: DNA APOBEC3G yang dibagi menjadi 3 fragmen telah berhasil didapat dan terklona ke dalam pBluescript KS (-). Pekerjaan lanjutan akan dilakukan untuk verifikasi sekuen fragmen-fragmen terklona dan menyambung ketiga fragrnen tersebut menjadi DNA APOBEC3G yang utub yang kemudian akan diklona ke dalam vektor ekspresi.

---

Background: APOBEC3G, apolipoprotein B rnRNA-cditing enzyme, catalytic polypeptide-like JG,is a human protein that interferes with the replication of HIV by incorporating itself into virus particles and damaging the genetic material of the virus. Several recent studies revealed that human APOBEC3G regulates HIVI infectivity by dearninating dC to dU in the newly synthesized minus strand DNA, resulting in G to A hypermutation of the viral plus strand DNA.Hypermutation induced by APOBEC3G may result in the introduction of stop codons in viral protein open reading frame and degradation of viral DNA by ura<:il-DNA glyoosylase, therefore blocking HlV replication. This protein is therefore suitable for further investigation for the development of ARV (AntiRetroviral) that is based on mechanism of blocking HIV-1 replication inhibition by APOBEC3G through the pathway. In order to obtain the APOBEC3G protein, an expression system of the APOBEC3G gene is required, which will be obtained by synthesis and cloning of the APOBEC3G gene into an expression vector.Method: To obtain the APOBEC3G mRNA that will be used as template for synthesis of APOBEC3G eDNA by RT-PCR using Omniscript enzyme, we performed RNA extraction from CEM-GFP cell line using the Rneasy Mini !Gt. In order to facilitate the synthesis of a complete APOBEC3G DNA, the APOBEC3G DNA double stranded was divided into three regions with overlapping nucleotide sequences at the DNA ends that function in the joining of the fragments into a full length APOBEC3G DNA.Results: The result of the experiments showed that the three fragments of APOBEC3G gene of 452 bp, 458 bp, and 433 bp, were successfully produced by PCR reaction using Pfx enzyme, and cloned into plasmid vector.Conclusions: APOBEC3G DNA that was divided into three fragments has been obtained and cloned illlo Bluescript KS (-) vector. Further study, will be performed to verifY the cloned fragments, and to fuse the fragments into a complete APOBEC3G DNA that will be cloned into an expression vector."

"Peran protein retinoblastoma (pRb) dalam pencegahan pembentukan tumor diinhibisi oleh interaksinya dengan protein E7 HPV pada kanker serviks. Oleh sebab itu, perlu dilakukan strategi pengembangan uji in vitro untuk analisis interaksi pRb dan E7, terutama dalam pengembangan vaksin HPV berbasis antigen E7. Protein pRb dapat diperoleh dalam bentuk protein rekombinan yang diproduksi pada bakteri Escherichia coli. Penelitian bertujuan untuk memperoleh klona gen RB1 dalam vektor pQE_80L. Sintesis gen RB1 (2787 pb) dilakukan dengan metode PCR overlap extension. Fragmen gen RB1 dan vektor didigesti dengan enzim restriksi BamHI dan SalI kemudian diligasikan dengan enzim T4 ligase. Hasil ligasi ditransformasi ke dalam Escherichia coli TOP10 secara kejut panas. Hasil transformasi diseleksi menggunakan PCR koloni untuk mengidentifikasi keberadaan DNA sisipan. Sebanyak 1 dari 27 koloni yang diseleksi mengandung plasmid rekombinan. Plasmid rekombinan kemudian diisolasi dan diverifikasi dengan digesti dan sekuensing. Hasil analisis digesti dan sekuensing menunjukkan gen RB1 berhasil disisipkan ke vektor pQE_80L. Namun terdapat beberapa mutasi, yaitu substitusi (c.117G>A dan c.2316T>C) serta mutasi delesi (c.719_724delAAACAG).

---

The role of human retinoblastoma protein (pRb) as tumor suppressor is inhibited by its interaction with HPV E7 protein in cervical cancer. Therefore, it is interesting to develop strategy for development of in vitro assay to analyze pRb and E7 interaction, especially in the development of therapeutic HPV vaccine that is based on E7 antigen. The pRb protein can be provided in the form of recombinant protein that is poduced in Escherichia coli. The study objective was to obtain RB1 gene clone in pQE_80L vector. The synthesis of RB1 gene (2787 pb) was performed by using overlap extension PCR. The RB1 gene fragment and vector was digested by BamHI and SalI restriction enzyme then ligated by T4 ligase enzyme. The ligation product was transformed into Escherichia coli TOP10 with heat shock. The transformation result was screened using colony PCR to identify the presence of insert DNA. There was 1 out of 27 selected colonies that carried the recombinant plasmid. The recombinant plasmid then isolated and verified with digestion and sequencing. The results of digestion and sequencing analysis showed that RB1 gene was successfully inserted into pQE_80L vector. However, there were mutations which were substitution (c.117G>A and c.2316T>C) and deletion (c.719_724delAAACAG)."

"Dr. Selma Rashid is a leading figure in hormone replacement therapy and anti-aging medicine. She is board-certified in internal medicine, yet refuses to practice medicine through standard medical protocols, which are not in her patients best interests. She passionately seeks answers to preventing the diseases and dysfunctions of aging.Her career in medicine was inspired by the complexity of the endocrine system. Very soon she was disheartened to learn that endocrinology operates like almost every other field of medicine, in a tight box of protocols, trying to treat diseases with medications and procedures, directed by the pharmaceutical and medical device companies.At every stage of her medical training she was perplexed as to why there was so little connection between the basic sciences learned in the first two years of medical school and the clinical training in the last two years. Although so much in medicine seemed noble and invaluable, most of what was going on did not make sense.The essence of her thought process is that the medical system should do everything possible to ensure that the diseases of aging are maximally prevented; and every person dies their natural death while fully functional, both physically and mentally."

"Background: VP6 protein is an intermediate layer on rotavirus outer capsid shell which is the major structural protein and play an important role in replication cycle. VP6 protein is a conserved region that can induce immune response as target protein of T cell with cross-reactive epitopes within another genotypes.Objectives: This research conducted to determine the molecular characterization of rotavirus VP6 recombinant protein of Indonesia strain, and to determine the clone and expression of VP6 protein in Escherichia coli BL21 for development of rotavirus vaccine.Methods: Rotavirus RNA was extracted from clinical sample of R55 and R10 strains that having correlation with genotipes I and II rotavirus. RNA samples were amplified with RT-PCR reaction and produced 1194 bp amplicon, and sequencing reaction were conducted to confirm and analyze the molecular characterization of VP6 protein in bioinformatics. VP6 gene as insert and pQE-80L plasmids as vector were double restricted and then ligated by ligation enzyme. Product of ligation were transformed to E.coli Top 10 competent cells and the clones were selected to get the recombinant plasmids which bearing VP6 gene. The recombinant plasmid than subcloned to E.coli BL21 competent cells and induced by IPTG and its pellets were loaded directly onto SDS-PAGE, approximately 45 kDa protein was observed on the SDS-PAGE. The protein was analyzed using Western-blotting.Results: Level of amino acids homology from R55 and R10 rotavirus strain compared with vaccine strains and vaccine candidate strains showed high level of homology, with the conserved regions of T-cell epitopes. R55 strain having close relativity with genotype I while R10 strain having close relativitywith genotype II. there are the same level of hydrophobicity between R55 and R10 which indicated as surface proteins or as a hydrophilic protein. The differences of secondary structure between R55 and R10 in amino acids position of 149-152 and 341-349. The VP6 cloned obtained from E.coli Top 10 with pQE-80L plasmid. The profile of expressed VP6 recombinant protein from R55 and R10 strains in SDS-PAGEshowed the different intensity of protein between induced condition with IPTG and non-induced condition, indicated that VP6 protein might be successfully expressed.The Western-Blot assay showed the same result between the cell that induced and non-induced, but it still need another confirmation.Conclusion: The resultof molecular characterization from VP6 recombinant protein and the cloned of VP6 gene that obtained from R55 and R10 rotavirus strains of Indonesia could beapplied as a preliminary study to develop rotavirus candidate vaccine based on subunit vaccine.

---

Latar belakang: Protein VP6 rotavirus adalah protrein struktural utama yang berperan penting selama replikasi, danmerupakan bagian yang paling lestaridan memiliki potensi dalam menstimulasi respon imun, yaitu sebagai protein target yang dapat menstimulasi sel T, dan memiliki epitop yang cross-reactive di antara genotipe rotavirus lainnya, sehingga memiliki potensi untuk dikembangkan sebagai vaksin.Tujuan: Untuk mengetahui karakterisasi molekular protein VP6 rotavirus strain Indonesia, serta pengklonaan gen dan ekspresi protein VP6 pada Escherichia coli BL21 untuk pengembangan vaksin rotavirus.Metode: RNA rotavirus R55 dan R10 diperoleh dari ekstraksi sampel klinis. RNA tersebut kemudian diamplifikasi dengan reaksi RT-PCR dan menghasilkan amplikon 1194 bp yang selanjutnya disekuensing untuk konfirmasi dan mengetahui karakterisasi molekular protein VP6 secara bioinformatika. Gen VP6 sebagai sisipan dan plasmid pQE-80L sebagai vektor direstriksi ganda dengan enzim restriksi dan diligasi menggunakan enzim ligasi. Produk ligasi ditransformasikan pada sel kompeten E.coli Top 10 dan diseleksi klon pembawa plasmid rekombinan. Plasmid rekombinan yang mengandung gen VP6 ditransformasikan ke sel kompeten E.coli BL21. Ekspresi protein dilakukan dengan induksi IPTG. Hasil ekspresi dianalisis dengan SDS-PAGE dan dikonfirmasi dengan Uji Western Blot.Hasil: Sekuen asam amino gen VP6 rotavirus strain Indonesia R55 dan R10 memiliki tingkat homologi yang tinggi dengan epitopyang lestari bila dibandingkan dengan strain vaksin dan kandidat vaksin rotavirus; strain R55 lebih dekat kekerabatannya dengan rotavirus genotipe I, strain R10 lebih dekat kekerabatannya dengan rotavirus genotipe II. Sekuen VP6 rotavirus strain R55 dan R10 menunjukkan tingkat hidrofobisitas yang sama, hal ini mengindikasikan sejenis protein permukaan atau protein yang bersifat hidrofilik. Hasil analisa struktur sekunder pada strain R55 dan R10 menunjukkan adanya perbedaan pada posisi asam amino 149-152 dan 341-349. Telah didapatkan klon pQE-80L yang mengandung gen VP6 dari strain R55 dan R10. Ekspresi protein VP6 pada SDS-PAGE menunjukkan adanya perbedaan intensitas pita protein antara sel E. coli yang diinduksi IPTG dengan yang tidak diinduksi, mengindikasikan protein VP6 diduga berhasil diekspresikan. Konfirmasi ekspresi protein menggunakan Western-Blot menunjukkan hasil yang sama antara sel yang diinduksi dengan yang tidak diinduksi, namun hasil ini perlu dikonfirmasi lebih lanjut.Kesimpulan: Hasil karakterisasi molekular protein VP6 rekombinan dan pengklonaan gen VP6 dari rotavirus strain Indonesia R55 dan R10 dapat dikembangkan sebagai studi awal pada pengembangan vaksin subunit berbasis protein VP6 rekombinan. Namun untuk tahap ekspresi protein rekombinan VP6 perlu optimasi lebih lanjut."

"Potensi keanekaragaman Indonesia memberikan peluang untuk mendapatkan mikroorganisme penghasil endo-β-1,4-glukanase yang mampu menghidrolisis selulosa. Bacillus amyloliquefaciens BPPTCC-RK2 telah berhasil diisolasi dari rayap. Gen endo-β-1,4-glukanase dikloning dari DNA genom B.amyloliquefaciens BPPTCC-RK2 menggunakan metode rekombinatorial dan diekspresikan secara fungsional di dalam E.coli. Didapatkan ORF sepanjang 1500 nukleotida yang menyandikan 499 asam amino dengan berat molekul 55 kDa. Gen dikloning kedalam pDEST14 dan dioverekspresi pada E.coli BL21-Star. Aktivitas tertinggi sebesar 26,05 U/mg protein setelah diinduksi dengan 1mM IPTG selama 24 jam. Enzim optimum pada pH 6,0 dan suhu 65℃ dan memiliki waktu paruh 90 menit pada suhu 60℃. Pada konsentrasi etanol 100 g/L, masih memberikan aktivitas hingga 78% setelah 24 jam.

---

Indonesia has potential biodiversity that provides opportunities to obtain endo-β-1,4-glucanase producing microorganism that could hydrolize cellulose. Bacillus amyloliquefaciens BPPTCC-RK2 have been isolated from termites. Endo-β-1,4-glucanase gene have been cloned from genomic DNA B.amyloliquefaciens BPPTCC-RK2 using recombinatorial method and functionally expressed in E.coli. A full length gene of endo-β-1,4-glucanase consisting 1500 nucleotides that encoded for a protein 499 amino acids with predicted molecular weight 55 kDa. Highest enzyme activity (26,05 U/mg) achieved after 24 hour induction with 1mM IPTG. The enzyme optimum at pH 6,0 and temperature 65℃ and 90 minutes half-life at 60℃. This enzyme give 78% residual activity after 24 hour incubation in 100 g/L ethanol."

"Bakteri Weissella confusa MBF 8-1 yang diisolasi dari produk ampas kacang kedelai terfermentasi telah diteliti memiliki aktivitas Bacteriocin Like Inhibitory Substance (BLIS) terhadap bakteri Leuconostoc mesenteroides. W. confusa MBF8-1 menyandikan tiga jenis bakteriosin yaitu bakteriosin 1 (Bac1), 2 (Bac2), dan 3 (Bac3). Di masa depan, diharapkan bakteriosin tersebut dapat digunakan sebagai peptida antimikroba baru maupun sebagai komplemen antibiotik. Penelitian ini bertujuan untuk menghasilkan vektor rekombinan pembawa gen bakteriosin 1 (bac1) yang dapat diintroduksi ke inang yang sesuai. Vektor rekombinan dikloning dengan metode rekombinatorial Gateway®. Amplifikasi bac1 dengan teknik PCR menggunakan primer yang didesain spesifik dari sekuens bac1 dengan tag attB. Produk PCR disisipkan ke plasmid pDONRTM221 lewat reaksi BP. Plasmid rekombinan selanjutnya ditransformasikan ke sel inang Escherichia coli DH5α. Keberadaan bac1 pada plasmid rekombinan diverifikasi dengan sekuensing. Transformasi yang dilakukan berhasil mengkloning bac1 ke vektor rekombinan, sehingga diperoleh plasmid pENT_Wcbac1 yang dapat digunakan untuk proses selanjutnya dalam ekspresi Bac1.

---

Weissella confusa MBF 8-1 was isolated from waste of fermented soya and showed Bacteriocin Like Inhibitory Substance (BLIS) activity against bacteria Leuconostoc mesenteroides. There are three types of bacteriocin produced by W. confusa MBF8-1: bacteriocin 1 (Bac1), 2 (Bac2), and 3 (Bac3). In the future, bacteriocin is potent either to be a new antimicrobial peptide or as antibiotics complement. This experiment was conducted to clone recombinant vector containing bacteriocin 1 gene (bac1) that later can be introduced to suitable expression system. Recombinant vector was cloned by Gateway® recombinatorial technique. First, bac1 was amplified by PCR, using specifically designed primers from bac1 sequence added with attB tag. The PCR product then inserted into pDONRTM221 by BP recombination reaction. Finally, the resulting recombinant plasmid was transformed to Escherichia coli DH5α. The bac1 was verified by sequencing. The transformation successfully cloned bac1 into recombinant vector, named pENT_Wcbac1, which later can be used in the next step of Bac1 expression."